PMID- 36759301 OWN - NLM STAT- MEDLINE DCOM- 20230411 LR - 20230411 IS - 0035-3787 (Print) IS - 0035-3787 (Linking) VI - 179 IP - 4 DP - 2023 Apr TI - From neurons to the neuro-glio-vascular unit: Seizures and brain homeostasis in networks. PG - 308-315 LID - S0035-3787(23)00748-8 [pii] LID - 10.1016/j.neurol.2022.12.005 [doi] AB - While seizures are undoubtedly neuronal events, an ensemble of auxiliary brain cells profoundly shapes synaptic transmission in health and disease conditions. Endothelial-astrocyte-pericyte assemblies at the blood-brain barrier (BBB) and neuroglia within the neuro-glio-vascular unit (NGVU) finely tune brain parenchymal homeostasis, safeguarding the ionic and molecular compositions of the interstitial fluid. BBB permeability with neuroinflammation and the resulting loss of brain homeostatic control are unifying mechanisms sustaining aberrant neuronal discharges, with temporal specificities linked to acute (head trauma, stroke, infections) and pre-existent (genetic) or chronic ( dysplasia, tumors, neurodegenerative disorders) pathological conditions. Within this research template, one hypothesis is that the topography of BBB damage and neuroinflammation could associate with symptoms, e.g., limbic structures for seizures or pre-frontal for psychiatric episodes. Another uncharted matter is whether seizure activity, without tissue lesions or sclerosis, is sufficient to promote stable cellular-level maladaptations in networks. Contingent to localization and duration, BBB damage and inflammation forecast pathological trajectories, and the concept of an epileptic NGVU could enable time-sensitive biomarkers to predict disease progression. The coherence between electrographic, imaging and molecular NGVU biomarkers could be established from the epileptogenic to the propagating zones. This paradigm shift could lead to new diagnostic and therapeutic modalities germane to specific epilepsies or when seizure activity represents a comorbidity. CI - Copyright (c) 2023 Elsevier Masson SAS. All rights reserved. FAU - Cresto, N AU - Cresto N AD - Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. FAU - Janvier, A AU - Janvier A AD - Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. FAU - Marchi, N AU - Marchi N AD - Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. Electronic address: nicola.marchi@igf.cnrs.fr. LA - eng PT - Journal Article PT - Review DEP - 20230208 PL - France TA - Rev Neurol (Paris) JT - Revue neurologique JID - 2984779R SB - IM MH - Humans MH - *Neuroinflammatory Diseases MH - Brain/pathology MH - Seizures/diagnosis/etiology MH - Blood-Brain Barrier/pathology MH - Neurons/pathology MH - *Epilepsy/diagnosis/etiology/pathology MH - Homeostasis OTO - NOTNLM OT - Astrocytes OT - Biomarkers OT - Blood-brain barrier OT - Epileptogenic OT - Homeostasis OT - Immunity OT - Inflammation OT - Microglia OT - Pericytes OT - Seizure propagation EDAT- 2023/02/10 06:00 MHDA- 2023/04/11 06:41 CRDT- 2023/02/09 22:03 PHST- 2022/11/08 00:00 [received] PHST- 2022/12/05 00:00 [revised] PHST- 2022/12/06 00:00 [accepted] PHST- 2023/04/11 06:41 [medline] PHST- 2023/02/10 06:00 [pubmed] PHST- 2023/02/09 22:03 [entrez] AID - S0035-3787(23)00748-8 [pii] AID - 10.1016/j.neurol.2022.12.005 [doi] PST - ppublish SO - Rev Neurol (Paris). 2023 Apr;179(4):308-315. doi: 10.1016/j.neurol.2022.12.005. Epub 2023 Feb 8.